Topic: ABBVIE
35 results were found.
AbbVie to acquire Landos Biopharma - March 26, 2024
AbbVie Q4 revenues $14.301 billion - February 5, 2024
AbbVie buys Immunogen for $10 billion - December 1, 2023
AbbVie Q3 revenues $13.927 billion - October 28, 2023
AbbVie Q2 profit up - July 27, 2023
AbbVie Q4 diluted EPS $1.38 - February 10, 2023
AbbVie signs $40 million collaboration deal with HotSpot Therapeutics - December 7, 2022
AbbVie Q3 net revenues $14.812 billion - October 31, 2022
Genmab files for approval of blood cancer drug in U.S., AbbVie gets review in EU - October 29, 2022
Oxford biomedical firm DJS Antibodies acquired by AbbVie for $225 million - October 28, 2022
AbbVie to acquire DJS Antibodies in $255m cash deal - October 25, 2022
AbbVie says CMHP recommends European approval of Risankizumab for treatment of Crohn's disease - September 19, 2022
AbbVie acquires Syndesi for $130m upfront - March 2, 2022
AbbVie Q4 profit $4.04 billion - February 3, 2022
U.S. FDA seeks new warnings on drugs from Pfizer, Lilly and AbbVie - September 2, 2021
AbbVie Q4 net earnings dropped to $36 million - February 4, 2021
AbbVie Q3 bottom line $2.31 billion - October 30, 2020
ACM closes investigation into drug manufacturer AbbVie - September 28, 2020
FTC approves final order imposing conditions on AbbVie’s acquisition of Allergan - September 5, 2020
AbbVie Q2 net revenues $10.425 billion - August 3, 2020
TRC Capital rides again: Now targets AbbVie with mini tender offer - June 13, 2020
AbbVie completes acquisition of Allergan - May 9, 2020
Clearance from U.S. Federal Trade Commission for AbbVie's acquisition of Allergan - May 6, 2020
AbbVie Q1 net revenues $8.619 billion - May 1, 2020
AbbVie Q4 net revenues $8.704 billion - February 7, 2020
AbbVie Q3 net revenues $8.479 billion - November 2, 2019
AbbVie Q2 net revenues $8.255 billion - July 29, 2019
AbbVie and affiliate owe $448 million in FTC antitrust case - June 30, 2018
Britain turns down AbbVie’s venetoclax for leukemia - February 15, 2017
Infinity ends Agreement with AbbVie, cuts workforce by 58% - June 28, 2016
AbbVie to acquire Stemcentrx in $5.8 billion deal - April 28, 2016
AbbVie Q4 adjusted net revenues $6.360 billion - February 1, 2016
Abbvie completes acquisition of Pharmacyclics - May 26, 2015
AbbVie sales jumps 10.5% to $5.040 billion - April 24, 2015
AbbVie will buy Pharmacyclics in $21 billion deal - March 5, 2015